These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 27350088)

  • 1. Serum thymosin α 1 levels in patients with chronic inflammatory autoimmune diseases.
    Pica F; Chimenti MS; Gaziano R; Buè C; Casalinuovo IA; Triggianese P; Conigliaro P; Di Carlo D; Cordero V; Adorno G; Volpi A; Perricone R; Garaci E
    Clin Exp Immunol; 2016 Oct; 186(1):39-45. PubMed ID: 27350088
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thymosins in multiple sclerosis and its experimental models: moving from basic to clinical application.
    Severa M; Zhang J; Giacomini E; Rizzo F; Etna MP; Cruciani M; Garaci E; Chopp M; Coccia EM
    Mult Scler Relat Disord; 2019 Jan; 27():52-60. PubMed ID: 30317071
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro effect of thymosin-alpha1 and interferon-alpha on Th1 and Th2 cytokine synthesis in patients with eAg-negative chronic hepatitis B.
    Loggi E; Gramenzi A; Margotti M; Cursaro C; Galli S; Vitale G; Grandini E; Scuteri A; Vukotic R; Andreone P; Bernardi M
    J Viral Hepat; 2008 Jun; 15(6):442-8. PubMed ID: 18221304
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A pilot study of thymosin alpha1 therapy for chronic hepatitis B patients.
    Arase Y; Tsubota A; Suzuki Y; Suzuki F; Kobayashi M; Someya T; Akuta N; Hosaka T; Saitoh S; Ikeda K; Kobayashi M; Kumada H
    Intern Med; 2003 Oct; 42(10):941-6. PubMed ID: 14606705
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The efficacy of thymosin α1 as immunomodulatory treatment for sepsis: a systematic review of randomized controlled trials.
    Liu F; Wang HM; Wang T; Zhang YM; Zhu X
    BMC Infect Dis; 2016 Sep; 16():488. PubMed ID: 27633969
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thymosin α1 plus routine treatment inhibit inflammatory reaction and improve the quality of life in AECOPD patients.
    Jia Z; Feng Z; Tian R; Wang Q; Wang L
    Immunopharmacol Immunotoxicol; 2015; 37(4):388-92. PubMed ID: 26250523
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effect of transcatheter arterial chemoembolization combined with thymosin alpha 1 on the autophagy of immune cells from advanced hepatocellular carcinoma].
    Fang SJ; Zheng LY; Zhao ZW; Fan XX; Xu M; Ji JS
    Zhonghua Yi Xue Za Zhi; 2017 Jul; 97(25):1942-1946. PubMed ID: 28693071
    [No Abstract]   [Full Text] [Related]  

  • 8. Effects of combined thymosin and hydrocortisone on immune response in septic mice.
    Zhang D; Zhou Y; Cheng Q
    Int J Clin Exp Med; 2015; 8(8):12989-94. PubMed ID: 26550219
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The anti-tumor efforts of thymosin alpha1 on tumor lysate-pulsed dendritic cells in colon cancer in vitro and in vivo].
    Ma YL; Zheng Z; Li BD; Xie SJ; Li GX; Yan QH; Cai JH
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2007 Nov; 23(11):1046-9. PubMed ID: 17988589
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Large randomized study of thymosin alpha 1, interferon alfa, or both in combination with dacarbazine in patients with metastatic melanoma.
    Maio M; Mackiewicz A; Testori A; Trefzer U; Ferraresi V; Jassem J; Garbe C; Lesimple T; Guillot B; Gascon P; Gilde K; Camerini R; Cognetti F;
    J Clin Oncol; 2010 Apr; 28(10):1780-7. PubMed ID: 20194853
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of ulinastatin combined with thymosin alpha1 on sepsis: A systematic review and meta-analysis of Chinese and Indian patients.
    Liu D; Yu Z; Yin J; Chen Y; Zhang H; Xin F; Fu H; Wan B
    J Crit Care; 2017 Jun; 39():259-266. PubMed ID: 28069319
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thymosin α1 promotes the activation of myeloid-derived suppressor cells in a Lewis lung cancer model by upregulating Arginase 1.
    Yuan C; Zheng Y; Zhang B; Shao L; Liu Y; Tian T; Gu X; Li X; Fan K
    Biochem Biophys Res Commun; 2015 Aug; 464(1):249-55. PubMed ID: 26111447
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circulating levels of matrix metalloproteinases MMP-3 and MMP-1, tissue inhibitor of metalloproteinases 1 (TIMP-1), and MMP-1/TIMP-1 complex in rheumatic disease. Correlation with clinical activity of rheumatoid arthritis versus other surrogate markers.
    Keyszer G; Lambiri I; Nagel R; Keysser C; Keysser M; Gromnica-Ihle E; Franz J; Burmester GR; Jung K
    J Rheumatol; 1999 Feb; 26(2):251-8. PubMed ID: 9972954
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differing local and systemic inflammatory burden in polyarticular psoriatic arthritis and rheumatoid arthritis patients on anti-TNF treatment in clinical remission.
    Ramírez J; Inciarte-Mundo J; Cuervo A; Ruiz-Esquide V; Hernández MV; Sanmartí R; Cañete JD
    Clin Exp Rheumatol; 2017; 35(1):74-79. PubMed ID: 27749227
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The efficacy and safety of thymosin alpha-1 in Japanese patients with chronic hepatitis B; results from a randomized clinical trial.
    Iino S; Toyota J; Kumada H; Kiyosawa K; Kakumu S; Sata M; Suzuki H; Martins EB
    J Viral Hepat; 2005 May; 12(3):300-6. PubMed ID: 15850471
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thymosin alpha-1-transformed Bifidobacterium promotes T cell proliferation and maturation in mice by oral administration.
    Shao C; Tian G; Huang Y; Liang W; Zheng H; Wei J; Wei C; Yang C; Wang H; Zeng W
    Int Immunopharmacol; 2013 Mar; 15(3):646-53. PubMed ID: 23352493
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thymosin α1 Interacts with Hyaluronic Acid Electrostatically by Its Terminal Sequence LKEKK.
    Mandaliti W; Nepravishta R; Pica F; Vallebona PS; Garaci E; Paci M
    Molecules; 2017 Oct; 22(11):. PubMed ID: 29077041
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thymosin α1 modulated the immune landscape of COVID-19 patients revealed by single-cell RNA and TCR sequencing.
    Bai H; Liang L; Qi X; Xu Y; Liu Y; Ren D; Cai Z; Mao W; Wang X; Qin H; Hu F; Shi B
    Int Immunopharmacol; 2023 Nov; 124(Pt B):110983. PubMed ID: 37769533
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thymosin alpha1: an endogenous regulator of inflammation, immunity, and tolerance.
    Romani L; Bistoni F; Montagnoli C; Gaziano R; Bozza S; Bonifazi P; Zelante T; Moretti S; Rasi G; Garaci E; Puccetti P
    Ann N Y Acad Sci; 2007 Sep; 1112():326-38. PubMed ID: 17495242
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunopharmacology of thymosin alpha1 and cytokine synergy.
    Naylor PH; Quadrini K; Garaci E; Rasi G; Hadden JW
    Ann N Y Acad Sci; 2007 Sep; 1112():235-44. PubMed ID: 17567942
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.